← Back to Search

eScreening for Mental Health in Veterans

N/A

Waitlist Available

Led By James Pittman, PhD MSW

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (6-18months), post (18-27months), and followup (27-36months).

Awards & highlights

No Placebo-Only Group

Summary

This trial will investigate whether electronic screening is more effective than usual screening for detecting suicidal ideation and other mental health symptoms in Veterans.

Who is the study for?

This trial is for VA staff involved in implementing eScreening, a system to detect mental health issues like depression and PTSD in Veterans. Participants must be able to give informed consent and play a role in the eScreening process at their site.

What is being tested?

The study tests how well eScreening works compared to usual screening methods for identifying mental health symptoms among Veterans. It also examines the effectiveness of a multi-component strategy for rolling out eScreening across VA Transition Care Management clinics.

What are the potential side effects?

Since this trial involves an electronic screening tool rather than medication, traditional side effects are not applicable. However, there may be indirect effects on workflow or data management that will be monitored.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (6-18months), post (18-27months), and followup (27-36months).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (6-18months), post (18-27months), and followup (27-36months).

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (6-18months), post (18-27months), and followup (27-36months). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in rate of screening completion

Change in time to screening completion

Secondary study objectives

Change in rate of referral to care

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Stepped-wedgeExperimental Treatment2 Interventions

This stepped-wedge trial relies on sequential roll-out of eScreening to participating sites over time, while using other sites as controls until they begin implementation.

Do I qualify?Apply below to find out